Items where Salford Author is "Mutti, L"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 27.

Article

Albelazi, MS, Martin, PR, Mohammed, S ORCID: https://orcid.org/0000-0002-3882-6129, Mutti, L, Parsons, JL and Elder, RH ORCID: https://orcid.org/0000-0003-4614-175X 2019, 'The biochemical role of the human NEIL1 and NEIL3 DNA glycosylases on model DNA replication forks' , Genes, 10 (4) , p. 315.
[img]
Preview

Guazzelli, A, Meysami, P, Bakker, E, Demonacos, C, Giordano, A, Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Mutti, L 2019, 'BAP1 status determines the sensitivity of malignant mesothelioma cells to gemcitabine treatment' , International Journal of Molecular Sciences, 20 (2) , p. 429.
[img]
Preview
[img]

Tian, K, Bakker, EY, Hussain, M, Guazzelli, A, Alhebshi, H, Meysami, P, Demonacos, C, Schwartz, J-M, Mutti, L and Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2018, 'p53 modeling as a route to mesothelioma patients' stratification and novel therapeutic identification' , Journal of Translational Medicine, 16 (282) .
[img]
Preview
[img]

Mutti, L, Peikert, T, Robinson, BWS, Scherpereel, A, Tsao, AS, de Perrot, M, Woodard, GA, Jablons, DM, Wiens, J, Hirsch, FR, Yang, H, Carbone, M, Thomas, A and Hassan, R 2018, 'State of the art : concise review scientific advances and new frontiers in mesothelioma therapeutics' , Journal of Thoracic Oncology, 13 (9) , pp. 1269-1283. Item not available from this repository.

Ricciardi, S, Cardillo, G, Zirafa, CC, Carleo, F, Facciolo, F, Fontanini, G, Mutti, L and Melfi, F 2018, 'Surgery for malignant pleural mesothelioma : an international guidelines review' , Journal of Thoracic Disease, 10 (Supp.2) , S285-S292. Item not available from this repository.

Bakker, EY, Tian, K, Mutti, L, Demonacos, C, Schwartz, J-M and Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2017, 'Insight into glucocorticoid receptor signalling through interactome model analysis' , PLOS Computational Biology, 13 (11) .
[img]
Preview
[img]
Preview

Bakker, EY, Guazzelli, A, Ashtiani, F, Demonacos, C, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Mutti, L 2017, 'Immunotherapy advances for mesothelioma treatment' , Expert Review of Anticancer Therapy, 17 (9) , pp. 799-814.
[img]
Preview
[img]

Guazzelli, A, Bakker, EY, Tian, K, Demonacos, C, Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Mutti, L 2017, 'Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma' , Expert Opinion on Investigational Drugs, 26 (8) , pp. 933-944.
[img]
Preview

De Santi, C, Melaiu, O, Bonotti, A, Cascione, L, Di Leva, G ORCID: https://orcid.org/0000-0002-7656-510X, Foddis, R, Cristaudo, A, Lucchi, M, Mora, M, Truini, A, Tironi, A, Murer, B, Boldorini, R, Cipollini, M, Gemignani, F, Gasparini, P, Mutti, L and Landi, S 2017, 'Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism' , Scientific Reports, 7 (2017) , #3140.
[img]
Preview
[img]

Qattan, MY, Bakker, EY, Rajendran, R, Wei-Chen Chen, D, Saha, V, Liu, J, Schwartz, J, Mutti, L, Demonacos, C and Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2017, 'Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia' , PLoS ONE, 12 (6) , e0178606.
[img]
Preview
[img]

Pattarozzi, A, Carra, E, Favoni, RE, Würth, R, Marubbi, D, Filiberti, R, Mutti, L, Florio, T, Barbieri, F and Daga, A 2017, 'The inhibition of FGF receptor 1 activity mediates sorafenib-induced antiproliferative effects in human mesothelioma tumor-initiating cells' , Stem Cell Research & Therapy, 8 (119) .
[img]
Preview
[img]

Bakker, EY, Guazzelli, A, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Lisanti, MP, Sotgia, F and Mutti, L 2017, 'Current and prospective pharmacotherapies for the treatment of pleural mesothelioma' , Expert Opinion on Orphan Drugs, 5 (6) , pp. 455-465.
[img]
Preview
[img]

De Santi, C, Pucci, P, Bonotti, A, Melaiu, O, Cipollini, M, Silvestri, R, Vymetalkova, V, Barone, E, Paolicchi, E, Corrado, A, Lepori, I, Dell’Anno, I, Pellè, L, Vodicka, P, Mutti, L, Foddis, R, Cristaudo, A, Gemignani, F and Landi, S 2017, 'Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals' , Occupational and Environmental Medicine, 74 (6) , pp. 457-464.
[img]
Preview

Guazzelli, A, Bakker, EY, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Lisanti, MP, Sotgia, F and Mutti, L 2017, 'Anti-CTLA-4 therapy for malignant mesothelioma' , Immunotherapy, 9 (3) , pp. 273-280.
[img]
Preview

Melaiu, O, Catalano, C, De Santi, C, Cipollini, M, Figlioli, G, Pellè, L, Barone, E, Evangelista, M, Guazzelli, Alice, Boldrini, L, Sensi, E, Bonotti, A, Foddis, R, Cristaudo, A, Mutti, L, Fontanini, G, Gemignani, F and Landi, S 2017, 'Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines' , Genes & Cancer, 8 (1-2) , pp. 438-452.
[img]
Preview
[img]

Nabavi, N, Bennewith, KL, Churg, A, Wang, Y, Collins, CC and Mutti, L 2017, 'Switching off malignant mesothelioma : exploiting the hypoxic microenvironment' , Genes & Cancer, 7 (11-12) , pp. 340-354.
[img]
Preview

Mutti, L 2016, 'A new standard for assessing asbestos exposure and its consequences?' , Journal Occupational Medicine, 73 (10) , pp. 709-710.
[img]
Preview
[img]

Fiorillo, M, Lamb, R, Tanowitz, H, Mutti, L, Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Cappello, A, Martinez-Outschoorn, U, Sotgia, Federica and Lisanti, MP 2016, 'Repurposing atovaquone : targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells' , Oncotarget, 7 (23) , pp. 34084-34099.
[img]
Preview

Paolicchi, E, Gemignani, F, Krstic-Demonacos, M, Dedhar, S, Mutti, L and Landi, S 2016, 'Targeting hypoxic response for cancer therapy' , Oncotarget, 7 (12) .
[img]
Preview

Guazzelli, A, Hussain, M, Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Mutti, L 2015, 'Tremelimumab for the treatment of malignant mesothelioma' , Expert opinion on biological therapy, 15 (12) , pp. 1819-1829.
[img]

Miluzio, A, Oliveto, S, Pesce, E, Mutti, L, Murer, B, Grosso, S, Ricciardi, S, Brina, D and Biffo, S 2015, 'Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo' , Oncotarget, 2015 (6) , pp. 37471-37485.
[img]
Preview

Mutti, L 2015, 'Malignant pleural mesothelioma : new ideas needed' , Lung Cancer Management, 4 (5) , pp. 201-203.
[img] [img]

Hussain, M, Tian, K, Mutti, L, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Schwartz, JM 2015, 'The expanded p53 interactome as a predictive model for cancer therapy' , Genomics and Computational Biology, 1 (1) , e20.
[img]
Preview

Bakker, EY, Qattan, M, Mutti, L, Demonacos, C and Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2015, 'The role of microenvironment and immunity in drug response in leukemia' , Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863 (3) , pp. 414-426.
[img] [img]
Preview

Melaiu, O, Melissari, E, Mutti, L, Bracci, E, De Santi, C, Iofrida, C, Di Russo, M, Cristaudo, A, Bonotti, A, Cipollini, M, Garritano, SI, Foddis, R, Lucchi, M, Pellegrini, S, Gemignani, F and Landi, S 2015, 'Expression status of candidate genes in mesothelioma tissues and cell lines' , Mutation research -Fundamental and Molecular Mechanisms of Mutagenesis, 771 , pp. 6-12. Item not available from this repository.

Garritano, S, De Santi, C, Silvestri, R, Melaiu, O, Cipollini, M, Barone, E, Lucchi, M, Barale, R, Mutti, L, Gemignani, F, Bonotti, A, Foddis, R, Cristaudo, A and Landi, S 2014, 'A common polymorphism within MSLN Affects miR-611 binding site and soluble mesothelin levels in healthy people' , Journal of Thoracic Oncology, 9 (11) , pp. 1662-1668. Item not available from this repository.

Ho, M, Melaiu, O, Stebbing, J, Lombardo, Y, Bracci, E, Uehara, N, Bonotti, A, Cristaudo, A, Foddis, R, Mutti, L, Barale, R, Gemignani, F, Giamas, G and Landi, S 2014, 'MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma' , PLoS ONE, 9 (1) , e85935.
[img]
Preview

This list was generated on Wed Feb 19 01:06:48 2020 UTC.